IL-1β: Clinical Trials

2 trials of IL-1β, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Active not recruiting 1

Follow IL-1β: new trials by email Literature Review of IL-1β trials Research Report on IL-1β

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MICROVASCULAR DAMAGE IN THROMBOTIC THROMBOCYTOPENIC PURPURA
Factor VIII (FVIII), Von Willebrand factor (VWF) antigen, VWF:RCo - TTP - Thrombotic Thrombocytopenic Purpura
Not applicableActive not recruitingFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico792026-02-282026-06-09
The ECMOCYP (cytochromes P450 Activity) Study
phenotype - ECMO, Cardiogenic Shock
RecruitingUniversity Hospital, Geneva462024-10-012024-10-28

Conditions studied

Purpura, Thrombotic Thrombocytopenic (1)  ·  Shock, Cardiogenic (1)

Sponsors

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (1)  ·  University Hospital, Geneva (1)

Countries

Italy (1)  ·  Switzerland (1)

NIH funding

2023 (1)